跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
E-6087
首页
药物
E-6087
E-6087
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Pyrazoline-derived compound and its use in a weekly dosage regime against inflammation and pain derived from degenerative joint disease in mammals
EP 3009137 A1
申请人: ECUPHAR N V
优先权: 2014
CN
EP
US
4 件公开
PYRAZOLINE-DERIVED COMPOUND (ENFLICOXIB) FOR USE IN THE PREVENTION AND/OR TREATMENT OF PAIN AND INFLAMMATION ASSOCIATED TO SURGERY IN MAMMALS
EP 4029502 A1
申请人: ECUPHAR N V
优先权: 2021
EP
Pyrazoline-derived compound for use in the prevention and/or treatment of pain and inflammation associated to surgery in mammals
US 12208085 B2
申请人: ECUPHAR NV
优先权: 2022
US
药物
反馈